Published in Blood Weekly, November 18th, 2004
The grant, which provides $1.5 million to researchers over a 3-year period, is designed to foster unique collaborations among researchers and institutions to help bring new therapies to clinic quickly.
This collaborative program, entitled "Development of Molecularly-Based Combination Therapy for Multiple Myeloma," is led by Kenneth C. Anderson, MD, Kraft Family Professor of Medicine and director of the Jerome Lipper Multiple Myeloma Center at the Dana-Farber Cancer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.